Neurogene Inc (NGNE) Implied Volatility Current

Tracking NGNE implied volatility helps you identify when options premiums on Neurogene Inc are historically cheap or expensive, and where the best trades are hiding. Neurogene Inc implied volatility reflects the market's expectation of future price movement: when NGNE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Neurogene Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NGNE, tracking metrics like NGNE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NGNE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NGNE implied volatility sits today versus where it has been. Our scanner ranks Neurogene Inc implied volatility against its historical range, surfaces extremes in NGNE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Neurogene Inc IV is rich or cheap — measure it, then act on it.